Cas:92632-81-0 5-(1,3-dioxoisoindol-2-yl)-4-oxopentanoic acid manufacturer & supplier

Chemical Name:5-(1,3-dioxoisoindol-2-yl)-4-oxopentanoic acid

CAS.NO:92632-81-0

Synonyms:phthalimidolevulinic acid;4-keto-5-phthalimido-valeric acid;5-Phthalimido-laevulinsaeure;5-phthalimido levulinic acid;4-Oxo-5-phthalimido-valeriansaeure;4-oxo-5-phthalimido-valeric acid;5-phthalimidyl levulinic acid

Molecular Formula:C₁₃H₁₁NO₅

Molecular Weight:261.23000

HS Code:2925190090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:91.75000

Exact Mass:261.06400

LogP:0.65440

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like phthalimidolevulinic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-phthalimidyl levulinic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Oxo-5-phthalimido-valeriansaeure Use and application,5-Phthalimido-laevulinsaeure technical grade,usp/ep/jp grade.

Related News: In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase. 5-(1,3-dioxoisoindol-2-yl)-4-oxopentanoic acid manufacturer The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. 5-(1,3-dioxoisoindol-2-yl)-4-oxopentanoic acid supplier In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 5-(1,3-dioxoisoindol-2-yl)-4-oxopentanoic acid vendor In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase. 5-(1,3-dioxoisoindol-2-yl)-4-oxopentanoic acid factory The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population.